Comparison of the sedative effect of intranasal midazolam and dexmedetomidine for pediatric
Phase 3
- Conditions
- Head trauma.
- Registration Number
- IRCT20190509043538N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 162
Inclusion Criteria
Children's age range from 1 year to 6 years old requires a CT scan.
Parental satisfaction to participate in this study.
Exclusion Criteria
Having excessive sensitivity to benzodiazepines and family members as well as alpha agonists
Alertness level based on the Glasgow Coma Score less than 15
Having very low blood pressure or shock
Having weak and unstable vital signs
Having lung disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success in sedation intranasally. Timepoint: 0,10,20,30 min. Method of measurement: By Ramsay scoring.
- Secondary Outcome Measures
Name Time Method Measurement of blood pressure ; pulse rate; blood oxygen saturation;. Timepoint: 0;10;20;30 minutes. Method of measurement: PulseOxymetery;Sphygmomanometer.